金纳多注射液联合地塞米松治疗突发性耳聋的效果及对血清ET、sVCAM-1、AECA水平的影响  

Effect of Gennadol Injection combined with Dexamethasone in the treatment of sudden deafness and its effect on serum ET,sVCAM-1 and AECA levels

作　　者：朱丽平 谭晓晔[2] 蒯烨滨 邵炳焕 ZHU Liping;TAN Xiaoye;KUAI Yebin;SHAO Binghuan(Department of Otolaryngology,Changzhou Maternal and Child Health Hospital,Jiangsu Province,Changzhou 213000,China;Department of Otolaryngology,the First People’s Hospital of Changzhou,Jiangsu Province,Changzhou 213000,China)

机构地区：[1]江苏省常州市妇幼保健院耳鼻咽喉科,江苏常州213000 [2]江苏省常州市第一人民医院耳鼻咽喉科,江苏常州213000

出　　处：《中国医药导报》2022年第6期106-109,共4页China Medical Herald

基　　金：江苏省重点研发计划专项资金项目(BE2018703)。

摘　　要：目的探究金纳多注射液联合地塞米松治疗突发性耳聋的效果及对血清内皮素(ET)、可溶性血管细胞间黏附因子-1(sVCAM-1)及抗内皮细胞抗体(AECA)水平的影响。方法选择2018年6月至2021年4月江苏省常州市妇幼保健院接诊的106例突发性耳聋患者作为研究对象,按照随机数字表法将其分为研究组和对照组,每组53例。对照组在常规治疗基础上给予地塞米松治疗,研究组在对照组基础上联合金纳多注射液治疗,两组维持给药1周。分别采用放射免疫法检测血清ET水平,双抗体夹心双抗体夹心酶联免疫吸附试验检测患者治疗前及治疗后3 d的血清sVCAM-1及AECA水平,并比较两组患者的临床疗效、症状改善时间及药物不良反应等情况。结果治疗过程中,对照组有2例中途退出,最终对照组纳入51例,研究组纳入53例。治疗后,两组血清ET、sVCAM-1及AECA表达水平较治疗前均降低,且研究组均低于对照组,差异有统计学意义(P<0.05)。研究组临床疗效优于对照组,差异有统计学意义(P<0.05)。研究组症状改善时间短于对照组,差异有统计学意义(P<0.05)。两组总不良反应发生率比较,差异无统计学意义(P>0.05)。结论给予突发性耳聋患者金纳多注射液联合地塞米松治疗,可缩短患者的症状改善时间,有效降低患者血清ET、sVCAM-1及AECA表达水平,临床疗效较佳且安全性良好。Objective To investigate the curative effect of Gennadol Injection combined with Dexamethasone in the treatment of sudden deafness and the effects on serum endothelin(ET),soluble vasccular cell adhesion molecule 1(sVCAM-1)and anti-endothelial cell antibody(AECA).Methods A total of 106 patients with sudden deafness admitted to Changzhou Maternal and Child Health Hospital of Jiangsu Province from June 2018 to April 2021 were selected as the research subjects,and they were divided into study group and control group according to random number table method,with 53 patients in each group.The control group was given Dexamethasone on the basis of conventional treatment,while the research group was given Nandol Injection on the basis of the control group.Both groups maintained administration for one week.Serum ET levels were detected by radioimmunoassay,serum sVCAM-1 and AECA levels were detected by double-antibody sandwich enzyme-linked immunosorbent assay before and three days after treatment,and clinical efficacy,symptom improvement time,and adverse drug reactions were compared between the two groups.Results During the treatment,two cases in the control group dropped out,and finally 51 cases in the control group and 53 cases in the study group were included.After treatment,the expression levels of ET,sVCAM-1,and AECA in serum of two groups were lower than before treatment,and the study group was lower than the control group,the differences were statistically significant(P<0.05).The clinical efficacy of the study group was better than that of the control group,and the difference was statistically significant(P<0.05).The symptom improvement time of the study group was shorter than that of the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of total adverse reactions between the two groups(P>0.05).Conclusion Treatment of patients with sudden deafness with Gennadol Injection combined with Dexamethasone can shorten the symptom improvement time of pa

关 键 词：金纳多注射液 地塞米松 突发性耳聋 临床疗效 血清内皮素 血清可溶性血管细胞间黏附因子-1 血清抗内皮细胞抗体 

分 类 号：R764.43[医药卫生—耳鼻咽喉科]